Business Description
The Cigna Group
NAICS : 524114
SIC : 6324
ISIN : US1255231003
Total Employee Number:
67,700Compare
Compare
Traded in other countries / regions
CI.USA0A77.UKCI.MexicoCGN.GermanyCIGN.AustriaC1IC34.Brazil1CI.Italy Index Membership
S&P 500Russell 1000Russell 3000MSCI World Index IPO Date
1982-04-01Description
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.25 | |||||
Equity-to-Asset | 0.28 | |||||
Debt-to-Equity | 0.73 | |||||
Debt-to-EBITDA | 2.46 | |||||
Interest Coverage | 6.11 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.8 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 21.2 | |||||
3-Year EBITDA Growth Rate | 3.5 | |||||
3-Year EPS without NRI Growth Rate | 8.5 | |||||
3-Year FCF Growth Rate | 9.9 | |||||
3-Year Book Growth Rate | 1.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 7.65 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.64 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 65.82 | |||||
9-Day RSI | 58.59 | |||||
14-Day RSI | 55.32 | |||||
3-1 Month Momentum % | 4.34 | |||||
6-1 Month Momentum % | 2.01 | |||||
12-1 Month Momentum % | -7.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.82 | |||||
Quick Ratio | 0.71 | |||||
Cash Ratio | 0.15 | |||||
Days Inventory | 8.66 | |||||
Days Sales Outstanding | 38.27 | |||||
Days Payable | 64.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.11 | |||||
Dividend Payout Ratio | 0.2 | |||||
3-Year Dividend Growth Rate | 10.5 | |||||
Forward Dividend Yield % | 2.15 | |||||
5-Year Yield-on-Cost % | 88.88 | |||||
3-Year Average Share Buyback Ratio | 4.1 | |||||
Shareholder Yield % | 4.62 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 8.82 | |||||
Operating Margin % | 3.1 | |||||
Net Margin % | 2.27 | |||||
EBITDA Margin % | 4.54 | |||||
FCF Margin % | 2.77 | |||||
OCF Margin % | 3.18 | |||||
ROE % | 15.25 | |||||
ROA % | 4.08 | |||||
ROIC % | 6.15 | |||||
3-Year ROIIC % | -11.5 | |||||
ROC (Joel Greenblatt) % | 267.82 | |||||
ROCE % | 9.94 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 12.28 | |||||
Forward PE Ratio | 9.53 | |||||
PE Ratio without NRI | 9.38 | |||||
Shiller PE Ratio | 11.52 | |||||
Price-to-Owner-Earnings | 10.76 | |||||
PS Ratio | 0.28 | |||||
PB Ratio | 1.82 | |||||
Price-to-Free-Cash-Flow | 10.09 | |||||
Price-to-Operating-Cash-Flow | 8.77 | |||||
EV-to-EBIT | 10.2 | |||||
EV-to-Forward-EBIT | 10.26 | |||||
EV-to-EBITDA | 7.96 | |||||
EV-to-Forward-EBITDA | 8.75 | |||||
EV-to-Revenue | 0.36 | |||||
EV-to-Forward-Revenue | 0.35 | |||||
EV-to-FCF | 13.05 | |||||
Price-to-Projected-FCF | 0.69 | |||||
Earnings Yield (Greenblatt) % | 9.8 | |||||
FCF Yield % | 9.99 | |||||
Forward Rate of Return (Yacktman) % | 8.14 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:CI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
The Cigna Group Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 276,882 | ||
| EPS (TTM) ($) | 23.59 | ||
| Beta | 0.0831 | ||
| 3-Year Sharpe Ratio | -0.01 | ||
| 3-Year Sortino Ratio | -0.01 | ||
| Volatility % | 35.09 | ||
| 14-Day RSI | 55.32 | ||
| 14-Day ATR ($) | 7.325335 | ||
| 20-Day SMA ($) | 286.0295 | ||
| 12-1 Month Momentum % | -7.18 | ||
| 52-Week Range ($) | 239.51 - 315.47 | ||
| Shares Outstanding (Mil) | 264.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
The Cigna Group Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
The Cigna Group Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-30 08:30 | In 114 days | ||
| Third quarter earnings results for 2026 | 2026-10-30 | In 113 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-30 08:30 | In 22 days | ||
| Second quarter earnings results for 2026 | 2026-07-30 06:30 | In 22 days | ||
| USD 1.560000 Cash Dividend | 2026-06-04 | 270.73 (-0.65%) | ||
| Guidance call for 2026 | 2026-05-13 12:20 | 298.49 (+2.93%) | ||
| First quarter earnings conference call for 2026 | 2026-04-30 08:30 | 292.32 (+3.16%) | ||
| First quarter earnings results for 2026 | 2026-04-30 06:30 | 292.32 (+3.16%) | ||
| General meeting for 2026 | 2026-04-22 11:00 | 276.69 (-2.57%) | ||
| USD 1.560000 Cash Dividend | 2026-03-05 | 284.74 (+1.29%) |
Show
Entries
The Cigna Group Frequently Asked Questions
What is The Cigna Group(CI)'s stock price today?
The current price of CI is $289.73. The 52 week high of CI is $315.47 and 52 week low is $239.51.
When is next earnings date of The Cigna Group(CI)?
The next earnings date of The Cigna Group(CI) is 2026-07-30.
Does The Cigna Group(CI) pay dividends? If so, how much?
The Dividend Yield %  of The Cigna Group(CI) is 2.11% (As of Today), Highest Dividend Payout Ratio of The Cigna Group(CI) was 0.21. The lowest was 0. And the median was 0.1. The  Forward Dividend Yield % of The Cigna Group(CI) is 2.15%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on NYSE:CI
Press Release
Articles on The Cigna Group
Headlines
See More- 1
Jul 08, 2026
Obamacare premiums could rise 14% in 2027
Seeking Alpha • 5:10am
Jun 22, 2026
Stock index futures slip as investors look for more U.S.-Iran talk updates
Seeking Alpha • 3:39am
Jun 21, 2026
AI may help hospitals more than insurers, UBS says
Seeking Alpha • 11:00am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers